Trial Profile
Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 May 2013
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications Gastritis
- Focus Therapeutic Use
- 23 Oct 2009 New trial record